Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D P Dearnaley

Showing results (151-160 of 185) with videos related to

Pageof 19
Sort By:
BJU International|June 26, 2003
Association between leptin receptor gene polymorphisms and early-onset prostate cancerZ Kote-Jarai, R Singh, F Durocher, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|May 20, 2005
Tumour staging using magnetic resonance imaging in clinically localised prostate cancer: relationship to biochemical outcome after neo-adjuvant androgen deprivation and radical radiotherapyA S N Jackson, C C Parker, A R Norman, et al.
British Journal of Cancer|January 1, 1997
No germline mutations in the dimerization domain of MXI1 in prostate cancer clusters. The CRC/BPG UK Familial Prostate Cancer Study Collaborators. Cancer Research Campaign/British Prostate GroupS M Edwards, D P Dearnaley, A Ardern-Jones, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|August 21, 2007
Target volume definition for head and neck intensity modulated radiotherapy: pre-clinical evaluation of PARSPORT trial guidelinesM T Guerrero Urbano, C H Clark, C Kong, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 1, 1994
A comparison of the palliative effects of strontium-89 and external beam radiotherapy in metastatic prostate cancerP M Quilty, D Kirk, J J Bolger, et al.
Seminars in Oncology|June 1, 1993
Strontium-89 (Metastron) versus external beam radiotherapy in patients with painful bone metastases secondary to prostatic cancer: preliminary report of a multicenter trial. UK Metastron Investigators GroupJ J Bolger, D P Dearnaley, D Kirk, et al.
Clinical Radiology|February 5, 2000
Dynamic contrast enhanced MRI of prostate cancer: correlation with morphology and tumour stage, histological grade and PSAA R Padhani, C J Gapinski, D A Macvicar, et al.
The British Journal of Radiology|October 3, 2007
Distortion-corrected T2 weighted MRI: a novel approach to prostate radiotherapy planningA S N Jackson, S A Reinsberg, S A Sohaib, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|June 11, 2019
Forward- and Inverse-Planned Intensity-Modulated Radiotherapy in the CHHiP Trial: A Comparison of Dosimetry and Normal Tissue ToxicityO F Naismith, C Griffin, I Syndikus, et al.
Journal of Human Nutrition and Dietetics : the Official Journal of the British Dietetic Association|April 21, 2012
Clinical trial: Efficacy of a low or modified fat diet for the prevention of gastrointestinal toxicity in patients receiving radiotherapy treatment for pelvic malignanciesL J Wedlake, C McGough, C Shaw, et al.
Pageof 19

Showing results (151-160 of 185) with videos related to

Sort By:
Pageof 19
BJU International|June 26, 2003
Association between leptin receptor gene polymorphisms and early-onset prostate cancerZ Kote-Jarai, R Singh, F Durocher, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|May 20, 2005
Tumour staging using magnetic resonance imaging in clinically localised prostate cancer: relationship to biochemical outcome after neo-adjuvant androgen deprivation and radical radiotherapyA S N Jackson, C C Parker, A R Norman, et al.
British Journal of Cancer|January 1, 1997
No germline mutations in the dimerization domain of MXI1 in prostate cancer clusters. The CRC/BPG UK Familial Prostate Cancer Study Collaborators. Cancer Research Campaign/British Prostate GroupS M Edwards, D P Dearnaley, A Ardern-Jones, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|August 21, 2007
Target volume definition for head and neck intensity modulated radiotherapy: pre-clinical evaluation of PARSPORT trial guidelinesM T Guerrero Urbano, C H Clark, C Kong, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 1, 1994
A comparison of the palliative effects of strontium-89 and external beam radiotherapy in metastatic prostate cancerP M Quilty, D Kirk, J J Bolger, et al.
Seminars in Oncology|June 1, 1993
Strontium-89 (Metastron) versus external beam radiotherapy in patients with painful bone metastases secondary to prostatic cancer: preliminary report of a multicenter trial. UK Metastron Investigators GroupJ J Bolger, D P Dearnaley, D Kirk, et al.
Clinical Radiology|February 5, 2000
Dynamic contrast enhanced MRI of prostate cancer: correlation with morphology and tumour stage, histological grade and PSAA R Padhani, C J Gapinski, D A Macvicar, et al.
The British Journal of Radiology|October 3, 2007
Distortion-corrected T2 weighted MRI: a novel approach to prostate radiotherapy planningA S N Jackson, S A Reinsberg, S A Sohaib, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|June 11, 2019
Forward- and Inverse-Planned Intensity-Modulated Radiotherapy in the CHHiP Trial: A Comparison of Dosimetry and Normal Tissue ToxicityO F Naismith, C Griffin, I Syndikus, et al.
Journal of Human Nutrition and Dietetics : the Official Journal of the British Dietetic Association|April 21, 2012
Clinical trial: Efficacy of a low or modified fat diet for the prevention of gastrointestinal toxicity in patients receiving radiotherapy treatment for pelvic malignanciesL J Wedlake, C McGough, C Shaw, et al.
Pageof 19